医療用大麻市場レポート 品種別(インディカ、サティバ、ハイブリッド)、誘導体別(カンナビジオール(CBD)、テトラヒドロカンナビノール(THC)、その他)、用途別(がん、関節炎、片頭痛、てんかん、その他)、最終用途別(製薬業界、研究開発センター、その他)、投与経路別(内服液・カプセル、気化器、外用薬、その他)、地域別 2025-2033

医療用大麻市場レポート 品種別(インディカ、サティバ、ハイブリッド)、誘導体別(カンナビジオール(CBD)、テトラヒドロカンナビノール(THC)、その他)、用途別(がん、関節炎、片頭痛、てんかん、その他)、最終用途別(製薬業界、研究開発センター、その他)、投与経路別(内服液・カプセル、気化器、外用薬、その他)、地域別 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A16263

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Medical Cannabis Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Species
    5.5    Market Breakup by Derivatives
    5.6    Market Breakup by Application
    5.7    Market Breakup by End-Use
    5.8    Market Breakup by Route of Administration
    5.9    Market Breakup by Region
    5.10    Market Forecast
    5.11    SWOT Analysis
        5.11.1    Overview
        5.11.2    Strengths
        5.11.3    Weaknesses
        5.11.4    Opportunities
        5.11.5    Threats
    5.12    Value Chain Analysis
        5.12.1    Input Suppliers
        5.12.2    Collectors
        5.12.3    Manufacturers
        5.12.4    Distributors
        5.12.5    Exporters
        5.12.6    Retailers
        5.12.7    End-User
    5.13    Porters Five Forces Analysis
        5.13.1    Overview
        5.13.2    Bargaining Power of Buyers
        5.13.3    Bargaining Power of Suppliers
        5.13.4    Degree of Competition
        5.13.5    Threat of New Entrants
        5.13.6    Threat of Substitutes
    5.14    Key Success and Risk Factors
6   Market Breakup by Species
    6.1    Indica
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Sativa
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Hybrid
        6.3.1 Market Trends
        6.3.2 Market Forecast
7   Market Breakup by Derivatives
    7.1    Cannabidiol (CBD)
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Tetrahydrocannabinol (THC)
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by Application
    8.1    Cancer
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Arthritis
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Migraine
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Epilepsy
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market Breakup by End-Use
    9.1    Pharmaceutical Industry
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Research and Development Centres
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Route of Administration
    10.1    Oral Solutions and Capsules
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Vaporizers
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Topicals
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4    Others
        10.4.1 Market Trends
        10.4.2 Market Forecast
11  Market Breakup by Region
    11.1    North America
        11.1.1    United States
             11.1.1.1 Market Trends
             11.1.1.2 Market Forecast
        11.1.2    Canada
             11.1.2.1 Market Trends
             11.1.2.2 Market Forecast
    11.2    Europe
        11.2.1    Germany
             11.2.1.1 Market Trends
             11.2.1.2 Market Forecast
        11.2.2    Italy
             11.2.2.1 Market Trends
             11.2.2.2 Market Forecast
        11.2.3    France
             11.2.3.1 Market Trends
             11.2.3.2 Market Forecast
        11.2.4    Netherlands
             11.2.4.1 Market Trends
             11.2.4.2 Market Forecast
        11.2.5    Spain
             11.2.5.1 Market Trends
             11.2.5.2 Market Forecast
    11.3    Latin America
        11.3.1 Market Trends
        11.3.2 Market Forecast
    11.4    Asia Pacific
        11.4.1 Market Trends
        11.4.2 Market Forecast
    11.5    Middle East and Africa
        11.5.1 Market Trends
        11.5.2 Market Forecast

12  Overview of Clinical Research Suggesting the Benefits of Medical Cannabis Across Various Indications

    12.1    Alzheimer’s Disease
    12.2    Autism 
    12.3    Cancer
    12.4    Chronic Pain
    12.5    Epilepsy
    12.6    Migraine
    12.7    Digestive Disorders
    12.8    Multiple Sclerosis 
    12.9    Schizophrenia
    12.10    Others
13  Competitive Landscape
    13.1    Market Structure
    13.2    Key Players
14  Key Player Profiles
    14.1    Canopy Growth Corporation
    14.2    GW Pharmaceuticals, plc
    14.3    Aurora Cannabis, Inc.
    14.4    Aphria, Inc.
    14.5    MedReleaf Corporation
    14.6    Insys Therapeutics, Inc.
    14.7    CanniMed Therapeutics, Inc.
    14.8    Cara Therapeutics, Inc.
    14.9    United Cannabis Corporation

医療用大麻市場レポート 品種別(インディカ、サティバ、ハイブリッド)、誘導体別(カンナビジオール(CBD)、テトラヒドロカンナビノール(THC)、その他)、用途別(がん、関節炎、片頭痛、てんかん、その他)、最終用途別(製薬業界、研究開発センター、その他)、投与経路別(内服液・カプセル、気化器、外用薬、その他)、地域別 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials